These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1407993)

  • 21. Approaches to the treatment of Sjögren's syndrome.
    Fox RI; Michelson P
    J Rheumatol Suppl; 2000 Dec; 61():15-21. PubMed ID: 11128699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prednisone and piroxicam for treatment of primary Sjögren's syndrome.
    Fox PC; Datiles M; Atkinson JC; Macynski AA; Scott J; Fletcher D; Valdez IH; Kurrasch RH; Delapenha R; Jackson W
    Clin Exp Rheumatol; 1993; 11(2):149-56. PubMed ID: 8508556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update on the management for the dental patient with Sjögren's syndrome and xerostomia.
    Rhodus NL
    Northwest Dent; 1999; 78(4):27-34. PubMed ID: 11819900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of mizoribine for the treatment of Sjögren's syndrome: a multicenter open-label clinical trial.
    Nakayamada S; Saito K; Umehara H; Ogawa N; Sumida T; Ito S; Minota S; Nara H; Kondo H; Okada J; Mimori T; Yoshifuji H; Sano H; Hashimoto N; Sugai S; Tanaka Y
    Mod Rheumatol; 2007; 17(6):464-9. PubMed ID: 18084697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sjögren's syndrome: current therapies remain inadequate for a common disease.
    Fox RI
    Expert Opin Investig Drugs; 2000 Sep; 9(9):2007-16. PubMed ID: 11060789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of low-dose doxycycline (LDD) on clinical symptoms of Sjögren's syndrome: a randomized, double-blind, placebo controlled cross-over study.
    Seitsalo H; Niemelä RK; Marinescu-Gava M; Vuotila T; Tjäderhane L; Salo T
    J Negat Results Biomed; 2007 Dec; 6():11. PubMed ID: 18163919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-related outcomes in Sjögren syndrome treated with stimulants of salivary secretion: Randomized clinical trial.
    da Mata ADSP; Amaral JPAR; Thomson WM; Barcelos F; Vaz Patto J; Pereira RMN; Marques DNDS
    Oral Dis; 2020 Mar; 26(2):313-324. PubMed ID: 31814226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sjogren's syndrome: evolving therapies.
    Fox RI
    Expert Opin Investig Drugs; 2003 Feb; 12(2):247-54. PubMed ID: 12556218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of physalaemin in the treatment of Sjogren's disease].
    Tamborini A; Perrotta P
    Ann Ottalmol Clin Ocul; 1969 Dec; 95(12):945-60. PubMed ID: 5408524
    [No Abstract]   [Full Text] [Related]  

  • 31. Sjogren's syndrome from the perspective of ophthalmology.
    Kuklinski E; Asbell PA
    Clin Immunol; 2017 Sep; 182():55-61. PubMed ID: 28476437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of steroid hormone on the salivary and lacrimal secretions in Sjögren's syndrome (author's transl)].
    Ichikawa Y; Yamauchi K; Shimizu Y; Arimori S
    Ryumachi; 1979 Feb; 19(1):15-22. PubMed ID: 424901
    [No Abstract]   [Full Text] [Related]  

  • 33. Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjögren's syndrome.
    Izumi M; Eguchi K; Nakamura H; Takagi Y; Kawabe Y; Nakamura T
    Ann Rheum Dis; 1998 Aug; 57(8):464-9. PubMed ID: 9797551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunolocalization of AQP5 in resting and stimulated normal labial glands and in Sjögren's syndrome.
    Gresz V; Horvath A; Gera I; Nielsen S; Zelles T
    Oral Dis; 2015 Jan; 21(1):e114-20. PubMed ID: 24661359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sjogren's syndrome: report of a case].
    Kanetani S; Kameda H; Oya N
    Kyoto Daigaku Kokukagaku Kiyo; 1966; 6(3):270-6. PubMed ID: 5229133
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bromhexine in symptomatic treatment of Sjögren syndrome].
    Fossaluzza V
    Klin Monbl Augenheilkd; 1984 Oct; 185(4):292-5. PubMed ID: 6513403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulated eccrine gland function in primary Sjögren's syndrome.
    Rees JL; Pal B
    Clin Exp Dermatol; 1989 May; 14(3):191-3. PubMed ID: 2591077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sjögren's syndrome, bromhexine, and tear secretion.
    Mackie I; Seal DV
    Br Med J; 1978 Aug; 2(6137):638. PubMed ID: 698633
    [No Abstract]   [Full Text] [Related]  

  • 39. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group.
    Vivino FB; Al-Hashimi I; Khan Z; LeVeque FG; Salisbury PL; Tran-Johnson TK; Muscoplat CC; Trivedi M; Goldlust B; Gallagher SC
    Arch Intern Med; 1999 Jan; 159(2):174-81. PubMed ID: 9927101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of Sjögren's syndrome with protease inhibitors].
    Matveĭkov GP; Soroka NF; Paliĭ LI
    Ter Arkh; 1988; 60(4):72-5. PubMed ID: 3293256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.